Eledon Pharmaceuticals (ELDN) Amortizatization of Intangibles (2015 - 2017)
Eledon Pharmaceuticals' (ELDN) quarterly Amortizatization of Intangibles came in at -$1000.0 in Q1 2017, up 97.3% YoY from -$506.85 in Q1 2016, and up 83.33% on a QoQ basis from -$6000.0 in Q4 2016.
Analysis
Eledon Pharmaceuticals (ELDN) Amortizatization of Intangibles (2015 - 2017) Analysis & Trends
Eledon Pharmaceuticals (ELDN) has 3 years of Amortizatization of Intangibles data on file, last reported at -$1000.0 in Q1 2017.
- Quarterly Amortizatization of Intangibles rose 97.3% year-over-year to -$1000.0 in Q1 2017, while the trailing twelve-month figure through Mar 2017 was -$79000.0 (changed N/A YoY) and the FY2016 annual result came in at -$115000.0, down 59.72% from the prior year.
- Amortizatization of Intangibles rose to -$1000.0 in Q1 2017, from -$6000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of -$1000.0 in Q1 2017 to a low of -$39000.0 in Q2 2016.
- A 3-year average of -$26714.3 and a median of -$33000.0 in 2015 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2016 — Amortizatization of Intangibles changed 0.0% — and 2017, when it soared 97.3%.
- Tracing ELDN's Amortizatization of Intangibles over 3 years: stood at -$38000.0 in 2015, then soared by 84.21% to -$6000.0 in 2016, then surged by 83.33% to -$1000.0 in 2017.
- The last three Amortizatization of Intangibles figures came in at -$1000.0 (Q1 2017), -$6000.0 (Q4 2016), and -$33000.0 (Q3 2016), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Eledon Pharmaceuticals | 344.87 Mn | 344.87 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | -1,000.00 |
| Dec 31, 2016 | -6,000.00 |
| Sep 30, 2016 | -33,000.00 |
| Jun 30, 2016 | -39,000.00 |
| Mar 31, 2016 | -37,000.00 |
| Dec 31, 2015 | -38,000.00 |
| Sep 30, 2015 | -33,000.00 |